Objective:

To emphasize the importance of vaccination as a preventive measure against respiratory infections, particularly for high-risk patients, and the role of respiratory therapists in this process.

Approach:

• Prevention Advocacy: Respiratory therapists can educate patients about the necessity of staying current with immunizations during various interactions.
• Vaccination Statistics: Highlighting the impact of influenza vaccination and the concerning trends in vaccination rates among adults and children.
• RSV and Pneumococcal Disease Awareness: Discussing the risks associated with RSV and pneumococcal disease, and the corresponding vaccination recommendations.
• Patient Engagement: Encouraging discussions about vaccination history and needs between patients and healthcare providers.

Key Findings:

• During the 2024-2025 influenza season, vaccination efforts led to the prevention of 10 million illnesses and 12,000 deaths, according to the CDC.
• Vaccination rates have declined, with only 41.9% of adults and 50.2% of children vaccinated in the 2024-2025 season, as reported by the CDC.
• RSV hospitalizes an estimated 110,000 to 180,000 adults aged 50 and above annually, according to CDC data.
• Pneumococcal vaccination is recommended for all adults aged 50 and older, as per CDC guidelines.

Limitations:

• Respiratory therapists may not have the authority to administer vaccines in all settings.

Conclusion:

Engaging patients in discussions about vaccinations can help improve awareness and uptake, particularly for those at risk of respiratory infections.

Sources:

• Centers for Disease Control and Prevention (CDC)
• Johns Hopkins Center on Aging and Health